Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for perioperative stress response and immune function in radical gastrectomy
ChiCTR2100047957Phase 4Not yet recruiting
- Sponsor
- Yixing People's Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (2 arms), sponsored by Yixing People's Hospital. Primary endpoints: adrenocorticotropic hormone, cortisol and 7 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2100047957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047957.